Mort Farina is a 69-year-old clincial compounding pharmacist in the US, who decided to have stem cell therapy following a heart attack and stroke. Mort chose to have his treatment at Hospital Angeles, part of the largest private hospital network in Mexico, and named as a Stem Cell Center of Excellence by US medical device manufacturer BioHeart Inc.
Recently BioHeart announced that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana, whose program with Regenerative Medicine Institute provides therapies for congestive heart failure (CHF) and peripheral arterial disease (PAD) patients.
Mort is the most recent patient to undergo treatment and describes his experience on a video available on You Tube, here.
Stem Cell therapy for CHF involves the use of stem cells derived from the patient’s own fat (adipose tissue) obtained using liposuction. Stem cells are then separated from the adipose tissue utilizing the fully-automated TGI Cell Isolation System, a process that takes about an hour. Recovered stem cells are injected into the patients’ hearts with Bioheart’s MyoCath® needle injection catheter.
“The ability to offer cutting edge treatments and regenerative medicine has provided new hope to these patients. We are very pleased with the positive outcomes seen in the patients treated so far, ” said treating cardiologist Dr. Parcero.
Among the patients treated utilizing the TGI Cell Isolation System, two have completed the 3-month follow-up testing. A significant improvement was seen in both the 6-minute walk as well as the left ventricular ejection fraction (LVEF). The first patient improved his walking distance from 315 to 420 meters and LVEF from 32% to 38%. The second patient improved his walking distance from 450 to 492 meters and LVEF from 40% to 55%.
At three months post-procedure, Mort says "What I noticed almost immediate was two things: my memory started getting bettter, and the second thing is that my daily nap is no longer necessary. Also that people keep commenting on how terrific I look."
When Mort told his physician in charge of heart transplant team at Cedars Sanai Medical Center was very encouraging about the procedure. "He thought it was a terrific idea and is very excited at following up on the treatment."
Mort has increased his exercise level and says "I do know that stem cells are the future of medicine. I hope the US will be smart enough, as they are in Mexico and Germany and South Korea and Tel Aviv, to start spending more time and emphasis on stem cell therapy."
Mort Farina is a 69-year-old clincial compounding pharmacist in the US, who decided to have stem cell therapy following a heart attack and stroke. Mort chose to have his treatment at Hospital Angeles, part of the largest private hospital network in Mexico, and named as a Stem Cell Center of Excellence by US medical device manufacturer BioHeart Inc.
Recently BioHeart announced that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana, whose program with Regenerative Medicine Institute provides therapies for congestive heart failure (CHF) and peripheral arterial disease (PAD) patients.
Mort is the most recent patient to undergo treatment and describes his experience on a video available on You Tube, here.
Stem Cell therapy for CHF involves the use of stem cells derived from the patient’s own fat (adipose tissue) obtained using liposuction. Stem cells are then separated from the adipose tissue utilizing the fully-automated TGI Cell Isolation System, a process that takes about an hour. Recovered stem cells are injected into the patients’ hearts with Bioheart’s MyoCath® needle injection catheter.
“The ability to offer cutting edge treatments and regenerative medicine has provided new hope to these patients. We are very pleased with the positive outcomes seen in the patients treated so far, ” said treating cardiologist Dr. Parcero.
Among the patients treated utilizing the TGI Cell Isolation System, two have completed the 3-month follow-up testing. A significant improvement was seen in both the 6-minute walk as well as the left ventricular ejection fraction (LVEF). The first patient improved his walking distance from 315 to 420 meters and LVEF from 32% to 38%. The second patient improved his walking distance from 450 to 492 meters and LVEF from 40% to 55%.
At three months post-procedure, Mort says "What I noticed almost immediate was two things: my memory started getting bettter, and the second thing is that my daily nap is no longer necessary. Also that people keep commenting on how terrific I look."
When Mort told his physician in charge of heart transplant team at Cedars Sanai Medical Center was very encouraging about the procedure. "He thought it was a terrific idea and is very excited at following up on the treatment."
Mort has increased his exercise level and says "I do know that stem cells are the future of medicine. I hope the US will be smart enough, as they are in Mexico and Germany and South Korea and Tel Aviv, to start spending more time and emphasis on stem cell therapy."